Table 2 Characteristics of the BASE-II study population divided by sex.
From: Relationship between Lipoprotein (a) and cognitive function – Results from the Berlin Aging Study II
Men (n = 659) | Women (n = 721) | p-value | |
|---|---|---|---|
Age [years] | 68 ± 3.6 | 68 ± 3.4 | <0.001 |
Weight [kg] | 83.95 ± 12.27 | 69.77 ± 12.34 | <0.001 |
Height [cm] | 175.55 ± 6.21 | 162.83 ± 6.02 | <0.001 |
BMI [kg/m2] | 27.23 ± 3.65 | 26.34 ± 4.62 | <0.001 |
Regular alcohol intake a | 598 (91.0) | 633 (87.8) | 0.055 |
Current smoking a | 73(11.1) | 63 (8.8) | <0.001 |
Physically inactive a | 73 (11.1) | 56 (7.8) | 0.04 |
GDS score | 24.61 (1.04) | 24.63 (1.05) | n.s. |
Cognitive function (factor scores). | |||
Verbal memory | −0.1805 ± 0.9406 | 0.2259 ± 0.8751 | <0.001 |
Visuo-construction | 0.1460 ± 0.9589 | −0.1276 ± 0.9381 | <0.001 |
Executive functions and processing speed | 0.0505 ± 0.9427 | −0.0708 ± 0.8245 | 0.032 |
Verbal fluency | −0.1015 ± 0.7355 | 0.1018 ± 0.7065 | <0.001 |
Lipid profile | |||
Total Cholesterol [mg/dL] | 202 ± 38 | 226 ± 38 | <0.001 |
HDL-C [mg/dL] | 55 ± 14 | 69 ± 16 | <0.001 |
LDL-C [mg/dL] | 123 ± 34 | 136 ± 35 | <0.001 |
TG [mg/dL] | 122 ± 77 | 104 ± 51 | <0.001 |
Lp(a) [mg/L] | 230.2 ± 320.6 | 265 ± 338.5 | 0.004 |
APOE genotypesa | |||
22 | 5 (0.8) | 3 (0.4) | n.s. |
23 | 89 (13.5) | 102 (14.1) | n.s. |
24 | 15 (2.3) | 25 (3.5) | n.s. |
33 | 394 (59.8) | 441 (61.2) | n.s. |
34 | 146 (22.2) | 138 (19.1) | n.s. |
44 | 10 (1.5) | 12 (1.7) | n.s. |
Vitamin B12 [ng/L] | 371.8 ± 213.5 | 423.1 ± 293.8 | <0.001 |
Homocysteine [µmol/L] | 14.29 ± 3.99 | 12.49 ± 3.44 | <0.001 |
CRP [mg/L] | 1.8 ± 2.4 | 2.2 ± 3.4 | 0.015 |
Folic acid [µg/L] | 10.88 ± 5.34 | 11.97 ± 5.77 | <0.001 |
HbA1c [%] | 5.7 ± 0.6 | 5.6 ± 0.5 | 0.012 |
TSH basal [mU/L] | 2.10 ± 3.07 | 2.29 ± 4.2 | 0.034 |
Sodium [mmol/L] | 139 ± 3 | 140 ± 3 | 0.005 |
Potassium [mmol/L] | 4.5 ± 0.4 | 4.5 ± 0.4 | n.s. |
Magnesium [mmol/L] | 0.82 ± 0.07 | 0.81 ± 0.07 | n.s. |